XML 102 R77.htm IDEA: XBRL DOCUMENT v3.25.1
CAPITAL STOCK (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Jul. 14, 2023
Oct. 31, 2017
Sep. 30, 2023
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Common stock, shares authorized       200,000,000 200,000,000 200,000,000
Common stock, par value       $ 0.001 $ 0.001 $ 0.001
Number of shares issued for merger, value           $ 143,377,654
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross       400,000    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares 100,000   300,000      
Expenses related to options       $ 430,457    
Unvested stock options       225,000    
Unvested stock options, grant date fair value       $ 1.5    
Stock Option Activity [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross       400,000    
Unrecognized compensation expense related to unvested stock options       $ 172,663    
Unrecognized compensation expense recognized over a weighted average vesting period       2 years 3 months    
Stock Award Activity [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares issued for services and equipment, shares           772,450
Number of shares issued for services and equipment, value           $ 1,631,701
Unrecognized compensation expense related to unvested stock options       $ 4,510,650 $ 8,104,771 $ 16,197,207
Unrecognized compensation expense recognized over a weighted average vesting period       2 years 4 months 28 days 2 years 8 months 26 days 2 years 4 months 24 days
Share-Based Payment Arrangement, Tranche One [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares     25,000      
2017 Equity Incentive Plan [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of common stock shares issued   9,000,000        
Shares available to be issued       2,791,492    
2017 Equity Incentive Plan [Member] | October 2020 [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Increase in issuance of equity-based instruments   4,515,000        
2017 Equity Incentive Plan [Member] | March 2023 [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Increase in issuance of equity-based instruments   1,000,000        
2017 Equity Incentive Plan [Member] | February 2024 [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Increase in issuance of equity-based instruments   3,000,000        
Common Stock [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares issued for merger, shares           20,000,000
Number of shares issued for merger, value           $ 20,000
Common Stock [Member] | 2017 Equity Incentive Plan [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of common stock shares issued   485,000        
Warrant [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Shares issued cashless exercise of warrants         99,762 374,584
Cashless exercise of warrants         100,000 443,110
Warrants outstanding       1,808,830    
Issuance of warrants, description       Each warrant provides the holder the right to purchase up to one share of our Common Stock at a predetermined exercise price. The outstanding warrants consist of (1) warrants to purchase 100,000 shares of Common Stock at an exercise price of $0.01 per share until March 2027; (2) warrants to purchase 911 shares of Common Stock at an exercise price of $1.65 per share until April 2025; (3) warrants to purchase 1,244,108 shares of our Common Stock at an exercise price of $2.00 per share consisting of approximately 1% of the warrants until August 2024, and approximately 99% until February 2026; (4) warrants to purchase 77,500 shares of Common Stock at an exercise price of $2.40 until September 2024, and (5) warrants to purchase 386,311 shares of Common Stock at an exercise price of $2.63 until November 2025.    
Warrant One [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Warrants issued to purchase common stock       100,000    
Warrants exercise price       $ 0.01    
Warrant Two [Member] | Until April 2025 [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Warrants issued to purchase common stock       911    
Warrants exercise price       $ 1.65    
Warrant Three [Member] | Until August 2024 [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Warrants issued to purchase common stock       1,244,108    
Warrants exercise price       $ 2    
Warrant Four [Member] | Until September 2024 [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Warrants issued to purchase common stock       77,500    
Warrants exercise price       $ 2.4    
Warrant Five [Member] | Until November 2025 [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Warrants issued to purchase common stock       386,311    
Warrants exercise price       $ 2.63    
Gemini Direct Investments LLC [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of shares issued for merger, shares           20,000,000
Number of shares issued for merger, value           $ 142,691,282
Investors [Member] | Warrant [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Stock issued during period shares warrants exercised, shares       31,750 200,003 431,080
Stock issued during period value warrants exercised, value       $ 76,200 $ 101,506 $ 943,907